US 12274747
Compositions and methods for treating cytokine release syndrome
granted A61KA61K35/17A61K38/1774
Quick answer
US patent 12274747 (Compositions and methods for treating cytokine release syndrome) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K35/17, A61K38/1774, A61K39/3955, A61K39/39558